3-[4-[(2S)-2-methylpiperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;1-methyl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;3-[4-[3-(triazol-1-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;1-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]pyrrolidine-3-carboxamide
C100H93F18N45O5 — CID 158143592
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-[(2S)-2-methylpiperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;1-methyl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;3-[4-[3-(triazol-1-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;1-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]pyrrolidine-3-carboxamide
3-[4-[(2S)-2-methylpiperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;1-methyl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;3-[4-[3-(triazol-1-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;1-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]pyrrolidine-3-carboxamide (PubChem CID 158143592) has the molecular formula C100H93F18N45O5 and a molecular weight of 2347.12 g/mol. Its IUPAC name is 3-[4-[(2S)-2-methylpiperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;1-methyl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;3-[4-[3-(triazol-1-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;1-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]pyrrolidine-3-carboxamide.
Molecular Properties
| Compound Name | 3-[4-[(2S)-2-methylpiperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;1-methyl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;3-[4-[3-(triazol-1-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;1-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]pyrrolidine-3-carboxamide |
|---|---|
| PubChem CID | 158143592 |
| Molecular Formula | C100H93F18N45O5 |
| Molecular Weight | 2347.12 g/mol |
| Exact Mass | 2345.81 |
| IUPAC Name | 3-[4-[(2S)-2-methylpiperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;1-methyl-4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;3-[4-[3-(triazol-1-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;4-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]piperazine-2-carboxamide;1-[2-[6-(trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-4-yl]pyrrolidine-3-carboxamide |
| SMILES | CN1CCN(c2ccnc(-c3cnc4cnc(C(F)(F)F)cn34)n2)CC1C(N)=O.C[C@H]1CCCCN1c1ccnc(-c2cnc3cnc(C(F)(F)F)cn23)n1.FC(F)(F)c1cn2c(-c3nccc(N4CCCC(n5ccnn5)C4)n3)cnc2cn1.NC(=O)C1CCN(c2ccnc(-c3cnc4cnc(C(F)(F)F)cn34)n2)C1.NC(=O)C1CN(c2ccnc(-c3cnc4cnc(C(F)(F)F)cn34)n2)CCN1.NC(=O)C1CN(c2ccnc(-c3cnc4cnc(C(F)(F)F)cn34)n2)CCO1 |
| InChI | InChI=1S/C18H16F3N9.C17H17F3N8O.C17H17F3N6.C16H15F3N8O.C16H14F3N7O2.C16H14F3N7O/c19-18(20,21)14-11-29-13(8-24-16(29)9-23-14)17-22-4-3-15(26-17)28-6-1-2-12(10-28)30-7-5-25-27-30;1-26-4-5-27(8-11(26)15(21)29)13-2-3-22-16(25-13)10-6-24-14-7-23-12(9-28(10)14)17(18,19)20;1-11-4-2-3-7-25(11)14-5-6-21-16(24-14)12-8-23-15-9-22-13(10-26(12)15)17(18,19)20;17-16(18,19)11-8-27-10(5-24-13(27)6-23-11)15-22-2-1-12(25-15)26-4-3-21-9(7-26)14(20)28;17-16(18,19)11-8-26-9(5-23-13(26)6-22-11)15-21-2-1-12(24-15)25-3-4-28-10(7-25)14(20)27;17-16(18,19)11-8-26-10(5-23-13(26)6-22-11)15-21-3-1-12(24-15)25-4-2-9(7-25)14(20)27/h3-5,7-9,11-12H,1-2,6,10H2;2-3,6-7,9,11H,4-5,8H2,1H3,(H2,21,29);5-6,8-11H,2-4,7H2,1H3;1-2,5-6,8-9,21H,3-4,7H2,(H2,20,28);1-2,5-6,8,10H,3-4,7H2,(H2,20,27);1,3,5-6,8-9H,2,4,7H2,(H2,20,27)/t;;11-;;;/m..0.../s1 |
| InChIKey | FUFZEFJRYVFFAU-JGARZUFISA-N |
| XLogP | 9.91 |
| TPSA | 582.83 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 46 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 168 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2347.12 |
| LogP ≤ 5 | 9.91 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 46 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158143592 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.